{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T16:18:13Z","timestamp":1783009093682,"version":"3.54.5"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1016\/j.intimp.2023.109710","type":"journal-article","created":{"date-parts":[[2023,1,16]],"date-time":"2023-01-16T10:00:50Z","timestamp":1673863250000},"page":"109710","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Decreased expression of ADAM10 on monocytes is associated with chronic allograft dysfunction in kidney transplant recipients"],"prefix":"10.1016","volume":"115","author":[{"given":"Yamei","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yangjuan","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueqiao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiwen","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunfei","family":"An","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengli","family":"Wan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shumeng","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lanlan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunying","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.intimp.2023.109710_b0005","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1111\/imr.12520","article-title":"Tim-3 and its role in regulating anti-tumor immunity","volume":"276","author":"Das","year":"2017","journal-title":"Immunol Rev"},{"issue":"7","key":"10.1016\/j.intimp.2023.109710_b0010","doi-asserted-by":"crossref","first-page":"2294","DOI":"10.3748\/wjg.v22.i7.2294","article-title":"Role of Tim-3 in hepatitis B virus infection: An overview","volume":"22","author":"Liu","year":"2016","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.intimp.2023.109710_b0015","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1189\/jlb.3HI0117-005RR","article-title":"Frontline Science: Tim-3-mediated dysfunctional engulfment of apoptotic cells in SLE","volume":"102","author":"Zhao","year":"2017","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.intimp.2023.109710_b0020","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.imlet.2015.11.004","article-title":"The amelioration of composite tissue allograft rejection by TIM-3-modified dendritic cell: Regulation of the balance of regulatory and effector T cells","volume":"169","author":"Wang","year":"2016","journal-title":"Immunol Lett"},{"key":"10.1016\/j.intimp.2023.109710_b0025","doi-asserted-by":"crossref","first-page":"5806","DOI":"10.4049\/jimmunol.0903435","article-title":"TIM-3: a novel regulatory molecule of alloimmune activation","volume":"185","author":"Boenisch","year":"2010","journal-title":"J Immunol"},{"key":"10.1016\/j.intimp.2023.109710_b0030","doi-asserted-by":"crossref","first-page":"e6904","DOI":"10.1590\/1414-431x20186904","article-title":"Non-invasive messenger RNA transcriptional evaluation in human kidney allograft dysfunction","volume":"51","author":"Joelsons","year":"2018","journal-title":"Braz J Med Biol Res"},{"key":"10.1016\/j.intimp.2023.109710_b0035","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1038\/ni1271","article-title":"The Tim-3 ligand galectin-9 negatively regulates T helper type 1 immunity","volume":"6","author":"Zhu","year":"2005","journal-title":"Nat Immunol"},{"key":"10.1016\/j.intimp.2023.109710_b0040","doi-asserted-by":"crossref","unstructured":"A.D. Anderson AC, Bregoli L, Hastings WD, Kassam N, Lei C, Chandwaskar R, Karman J, Su EW, Hirashima M, Bruce JN, Kane LP, Kuchroo VK, Hafler DA., Promotion of Tissue Inflammation by the Immune Receptor Tim-3 Expressed on Innate Immune Cells. Science 318 (2007) 1141-3.","DOI":"10.1126\/science.1148536"},{"issue":"7865","key":"10.1016\/j.intimp.2023.109710_b0045","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/s41586-021-03626-9","article-title":"TIM-3 restrains anti-tumour immunity by regulating inflammasome activation","volume":"595","author":"Dixon","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.intimp.2023.109710_b0050","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.intimp.2018.01.008","article-title":"Soluble Tim-3 and Gal-9 are associated with renal allograft dysfunction in kidney transplant recipients: A cross-sectional study","volume":"55","author":"Li","year":"2018","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.intimp.2023.109710_b0055","doi-asserted-by":"crossref","first-page":"34529","DOI":"10.1074\/jbc.M113.488478","article-title":"A disintegrin and metalloprotease (ADAM) 10 and ADAM17 are major sheddases of T cell immunoglobulin and mucin domain 3 (Tim-3)","volume":"288","author":"Moller-Hackbarth","year":"2013","journal-title":"J Biol Chem"},{"key":"10.1016\/j.intimp.2023.109710_b0060","doi-asserted-by":"crossref","first-page":"3723","DOI":"10.1128\/JVI.00006-15","article-title":"Soluble T cell immunoglobulin mucin domain 3 is shed from CD8+ T cells by the sheddase ADAM10, is increased in plasma during untreated HIV infection, and correlates with HIV disease progression","volume":"89","author":"Clayton","year":"2015","journal-title":"J Virol"},{"key":"10.1016\/j.intimp.2023.109710_b0065","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1038\/s41577-018-0068-5","article-title":"The emerging role of ADAM metalloproteinases in immunity","volume":"18","author":"Lambrecht","year":"2018","journal-title":"Nat Rev Immunol"},{"issue":"10","key":"10.1016\/j.intimp.2023.109710_b0070","doi-asserted-by":"crossref","first-page":"e76853","DOI":"10.1371\/journal.pone.0076853","article-title":"Differential surface expression of ADAM10 and ADAM17 on human T lymphocytes and tumor cells","volume":"8","author":"Ebsen","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.intimp.2023.109710_b0075","doi-asserted-by":"crossref","unstructured":"N.G.S. Elvira Lopez-Perez, and Fre \u0301de \u0301ric Checler, Proprotein Convertase Activity Contributes to the Processing of the Alzheimer\u2019s \u03b2-Amyloid Precursor Protein in Human Cells: Evidence for a Role of the Prohormone Convertase PC7 in the Constitutive \u03b1-Secretase Pathway. J Neurochem 73 (1999) 2056-62.","DOI":"10.1046\/j.1471-4159.1999.02056.x"},{"key":"10.1016\/j.intimp.2023.109710_b0080","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1096\/fj.01-0007fje","article-title":"WolfgangGarten, RolfPostina, andFalkFahrenholz, Regulation of the alpha-secretase ADAM10 by its prodomain and proprotein convertases","volume":"15","author":"AndreasAnders","year":"2001","journal-title":"FASEB J"},{"key":"10.1016\/j.intimp.2023.109710_b0085","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1038\/ki.2008.181","article-title":"Characterization of CXCL16 and ADAM10 in the normal and transplanted kidney","volume":"74","author":"Schramme","year":"2008","journal-title":"Kidney Int"},{"key":"10.1016\/j.intimp.2023.109710_b0090","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1093\/ndt\/gfr583","article-title":"ADAM17 up-regulation in renal transplant dysfunction and non-transplant-related renal fibrosis","volume":"27","author":"Mulder","year":"2012","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.intimp.2023.109710_b0095","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1159\/000320467","article-title":"The role of tumor necrosis factor-alpha converting enzyme in renal transplant rejection","volume":"32","author":"Wang","year":"2010","journal-title":"Am J Nephrol"},{"key":"10.1016\/j.intimp.2023.109710_b0100","doi-asserted-by":"crossref","first-page":"449","DOI":"10.3389\/fimmu.2013.00449","article-title":"Tim-3: an activation marker and activation limiter of innate immune cells","volume":"4","author":"Han","year":"2013","journal-title":"Front Immunol"},{"issue":"15","key":"10.1016\/j.intimp.2023.109710_b0105","doi-asserted-by":"crossref","DOI":"10.15252\/embj.201899456","article-title":"Proteolytic ectodomain shedding of membrane proteins in mammals-hardware, concepts, and recent developments","volume":"37","author":"Lichtenthaler","year":"2018","journal-title":"EMBO J"},{"key":"10.1016\/j.intimp.2023.109710_b0110","doi-asserted-by":"crossref","first-page":"3181","DOI":"10.4049\/jimmunol.1601298","article-title":"Tim-3 is a Marker of Plasmacytoid Dendritic Cell Dysfunction during HIV Infection and Is Associated with the Recruitment of IRF7 and p85 into Lysosomes and with the Submembrane Displacement of TLR9","volume":"198","author":"Schwartz","year":"2017","journal-title":"J Immunol"},{"key":"10.1016\/j.intimp.2023.109710_b0115","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1038\/ni.2376","article-title":"Tumor-infiltrating DCs suppress nucleic acid-mediated innate immune responses through interactions between the receptor TIM-3 and the alarmin HMGB1","volume":"13","author":"Chiba","year":"2012","journal-title":"Nat Immunol"},{"key":"10.1016\/j.intimp.2023.109710_b0120","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1016\/j.immuni.2021.04.019","article-title":"The inhibitory receptor TIM-3 limits activation of the cGAS-STING pathway in intra-tumoral dendritic cells by suppressing extracellular DNA uptake","volume":"54","author":"de Mingo Pulido","year":"2021","journal-title":"Immunity"},{"key":"10.1016\/j.intimp.2023.109710_b0125","doi-asserted-by":"crossref","first-page":"11738","DOI":"10.1074\/jbc.M805894200","article-title":"ADAM10, the rate-limiting protease of regulated intramembrane proteolysis of Notch and other proteins, is processed by ADAMS-9, ADAMS-15, and the gamma-secretase","volume":"284","author":"Tousseyn","year":"2009","journal-title":"J Biol Chem"},{"key":"10.1016\/j.intimp.2023.109710_b0130","doi-asserted-by":"crossref","first-page":"40443","DOI":"10.1074\/jbc.M111.280495","article-title":"ADAM9 inhibition increases membrane activity of ADAM10 and controls alpha-secretase processing of amyloid precursor protein","volume":"286","author":"Moss","year":"2011","journal-title":"J Biol Chem"},{"key":"10.1016\/j.intimp.2023.109710_b0135","doi-asserted-by":"crossref","first-page":"56","DOI":"10.3389\/fnmol.2017.00056","article-title":"Regulation of Alpha-Secretase ADAM10 In vitro and In vivo: Genetic, Epigenetic, and Protein-Based Mechanisms","volume":"10","author":"Endres","year":"2017","journal-title":"Front Mol Neurosci"},{"issue":"2","key":"10.1016\/j.intimp.2023.109710_b0140","doi-asserted-by":"crossref","first-page":"F333","DOI":"10.1152\/ajprenal.00625.2018","article-title":"Role of ADAM17 in kidney disease","volume":"317","author":"Palau","year":"2019","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.intimp.2023.109710_b0145","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1016\/j.intimp.2008.11.013","article-title":"Detection of the Tim-3 ligand, galectin-9, inside the allograft during a rejection episode","volume":"9","author":"Naka","year":"2009","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.intimp.2023.109710_b0150","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pneurobio.2015.10.003","article-title":"The alpha secretase ADAM10: A metalloprotease with multiple functions in the brain","volume":"135","author":"Saftig","year":"2015","journal-title":"Prog Neurobiol"},{"key":"10.1016\/j.intimp.2023.109710_b0155","doi-asserted-by":"crossref","first-page":"295","DOI":"10.3389\/fimmu.2020.00295","article-title":"Soluble CD30, the Immune Response, and Acute Rejection in Human Kidney Transplantation: A Systematic Review and Meta-Analysis","volume":"11","author":"Mirzakhani","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.intimp.2023.109710_b0160","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1093\/ndt\/gfy382","article-title":"Plasma kidney injury molecule-1 (p-KIM-1) levels and deterioration of kidney function over 16 years","volume":"35","author":"Schulz","year":"2020","journal-title":"Nephrol Dial Transplant"}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576923000334?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576923000334?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,9]],"date-time":"2025-01-09T14:11:09Z","timestamp":1736431869000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576923000334"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2]]},"references-count":32,"alternative-id":["S1567576923000334"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2023.109710","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2023,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Decreased expression of ADAM10 on monocytes is associated with chronic allograft dysfunction in kidney transplant recipients","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2023.109710","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"109710"}}